The onset of meningitis can occur suddenly and progress rapidly, with the potential to become fatal within a matter of hours. Survivors can be left with debilitating neurological side effects ranging from speech disorders to mental retardation and paralysis.
Since 2011, Sabin has worked to improve meningococcal disease estimates, focusing on Latin America. Through regional symposia, research and advocacy, Sabin provides a broader base of knowledge on which to build future initiatives, while bringing together key stakeholders to better understand and fight meningococcal disease.
Dr. F. Marc LaForce Receives 2012 Albert B. Sabin Gold Medal Award
May 7, 2012
Researchers find high incidence rates and deaths in first-ever analysis of the disease impac
From 19-20 March 2012, 181 people from 21countries discussed the strategies needed to prevent and control meningococcal meningitis Latin America and the Caribbean. Vaccines were at the top of the agenda.
Click on the links above to see proceedings from these discussions. English and Spanish versions available.
Buenos Aires, Argentina—March 15, 2012—Heath experts from throughout the Americas will reveal ne
April 23, 2010